These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 9877527)

  • 1. Huntington disease: clinical, genetic, and social aspects.
    Nance MA
    J Geriatr Psychiatry Neurol; 1998; 11(2):61-70. PubMed ID: 9877527
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Clinical characteristics of Huntington disease in two pedigrees and analysis of expanded CAG trinucleotide repeat].
    Cao GN; Bao XH; Lu HM; Zhang JJ; Ma YN; Gu WH; Xiong H; Qin J; Wu XR
    Beijing Da Xue Xue Bao Yi Xue Ban; 2011 Apr; 43(2):163-7. PubMed ID: 21503105
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DNA testing for Huntington disease in the Turkish population.
    Akbas F; Erginel-Unaltuna N
    Eur Neurol; 2003; 50(1):20-4. PubMed ID: 12824708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Weight loss in Huntington disease increases with higher CAG repeat number.
    Aziz NA; van der Burg JM; Landwehrmeyer GB; Brundin P; Stijnen T; ; Roos RA
    Neurology; 2008 Nov; 71(19):1506-13. PubMed ID: 18981372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genetics and neuropathology of Huntington's disease.
    Reiner A; Dragatsis I; Dietrich P
    Int Rev Neurobiol; 2011; 98():325-72. PubMed ID: 21907094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cognitive changes in asymptomatic carriers of the Huntington disease mutation gene.
    Verny C; Allain P; Prudean A; Malinge MC; Gohier B; Scherer C; Bonneau D; Dubas F; Le Gall D
    Eur J Neurol; 2007 Dec; 14(12):1344-50. PubMed ID: 17941857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The clinical and genetic features of Huntington disease.
    Sturrock A; Leavitt BR
    J Geriatr Psychiatry Neurol; 2010 Dec; 23(4):243-59. PubMed ID: 20923757
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Huntington disease: pathogenesis and treatment.
    Dayalu P; Albin RL
    Neurol Clin; 2015 Feb; 33(1):101-14. PubMed ID: 25432725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Patterns of meiotic variability of the (CAG)n repeat in the Huntington disease gene.
    Lucotte G; Gérard N; Aouizérate A; Loirat F; Hazout S
    Genet Couns; 1997; 8(2):77-81. PubMed ID: 9219003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [From gene to disease; HD gene and Huntington disease].
    Maat-Kievit JA; Losekoot M; Roos RA
    Ned Tijdschr Geneeskd; 2001 Nov; 145(44):2120-3. PubMed ID: 11723754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanding the Spectrum of Genes Involved in Huntington Disease Using a Combined Clinical and Genetic Approach.
    Mariani LL; Tesson C; Charles P; Cazeneuve C; Hahn V; Youssov K; Freeman L; Grabli D; Roze E; Noël S; Peuvion JN; Bachoud-Levi AC; Brice A; Stevanin G; Durr A
    JAMA Neurol; 2016 Sep; 73(9):1105-14. PubMed ID: 27400454
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The diagnosis and natural history of Huntington disease.
    Pagan F; Torres-Yaghi Y; Altshuler M
    Handb Clin Neurol; 2017; 144():63-67. PubMed ID: 28947126
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ancient origin of the CAG expansion causing Huntington disease in a Spanish population.
    García-Planells J; Burguera JA; Solís P; Millán JM; Ginestar D; Palau F; Espinós C
    Hum Mutat; 2005 May; 25(5):453-9. PubMed ID: 15832309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention of depressive behaviour in the YAC128 mouse model of Huntington disease by mutation at residue 586 of huntingtin.
    Pouladi MA; Graham RK; Karasinska JM; Xie Y; Santos RD; Petersén A; Hayden MR
    Brain; 2009 Apr; 132(Pt 4):919-32. PubMed ID: 19224899
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Autopsy-proven Huntington's disease with 29 trinucleotide repeats.
    Kenney C; Powell S; Jankovic J
    Mov Disord; 2007 Jan; 22(1):127-30. PubMed ID: 17115386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An autopsy case with clinically and molecular genetically diagnosed Huntington's disease with only minimal non-specific neuropathological findings.
    Mizuno H; Shibayama H; Tanaka F; Doyu M; Sobue G; Iwata H; Kobayashi H; Yamada K; Iwai K; Takeuchi T; Hashimoto N; Ishihara R; Ibuki Y; Ogasawara S; Ozeki M
    Clin Neuropathol; 2000; 19(2):94-103. PubMed ID: 10749290
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Usefulness of molecular testing in Huntington's disease.
    Wang V; Yeh TP; Chen CM; Yan SH; Soong BW
    Zhonghua Yi Xue Za Zhi (Taipei); 1999 Sep; 62(9):586-90. PubMed ID: 10502848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Huntington's disease: clinical presentation and treatment.
    Novak MJ; Tabrizi SJ
    Int Rev Neurobiol; 2011; 98():297-323. PubMed ID: 21907093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How does the Huntington's disease mutation damage cells?
    Rubinsztein DC
    Sci Aging Knowledge Environ; 2003 Sep; 2003(37):PE26. PubMed ID: 13679594
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Juvenile onset Huntington's disease--clinical and research perspectives.
    Nance MA; Myers RH
    Ment Retard Dev Disabil Res Rev; 2001; 7(3):153-7. PubMed ID: 11553930
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.